Pro Medicus has seen a significant boost in market confidence, with Bell Potter upgrading its price target to $260, nearly doubling its previous estimate. The company recently secured a landmark 10-year, $330 million contract with a major U.S. hospital system, reflecting its successful transition to larger public systems. Despite impressive growth figures, including a 30%-40% increase in revenues, concerns about its high valuation persist, prompting some analysts to recommend caution before further investment.